TrialThe British journal of dermatology2020

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

D M Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.